Safety study of STLX-2012 in healthy volunteers
This trial tests a new drug called STLX-2012 in healthy volunteers to check how safe it is and how the body handles it. Participation helps determine the right dose for future studies, but it is not intended to treat any disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old.
- Have a body mass index (BMI) between 18 and 32 – a healthy weight range.
- Be generally healthy, with no major chronic conditions (like heart, lung, kidney, or psychiatric disease).
- Have normal kidney and liver function.
- Not be pregnant or breastfeeding, and use effective birth control for 30 days after the last dose.
- No severe drug allergies or prior treatment with an IL-1RAP antibody (a type of targeted therapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called BLX-7006 in healthy adults to see if it is safe and to learn how the body handles it. Participating could help decide if the drug should be tested in people with certain conditions later.
This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.
This study tests a new investigational drug called BLX-0871 in healthy adults to see how safe it is and how the body processes it. Participation may help determine the right dose for future studies, but it will not treat any existing condition.
This trial tests the safety and how the body handles a new drug called ALXN2230 in healthy people. It helps find the right dose and checks for side effects.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests a new drug called QLS2312, given as an injection, to see if it is safe and how the body handles it. It is an early study in healthy volunteers that helps decide if the drug can be studied in people with certain conditions.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.